Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3993201000168112 | Irbesartan HCTZ 300 mg/12.5 mg (Apotex) (hydrochlorothiazide 12.5 mg + irbesartan 300 mg) tablet, 14 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3993211000168110 | Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 14 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 14 | Is a | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 14 | true | Inferred relationship | Some | ||
| Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 14 | has TPUU | Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet | true | Inferred relationship | Some | 1 | |
| Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 14 | has TP | Irbesartan HCTZ 300 mg/12.5 mg (Apotex) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 14, blister pack | Is a | True | Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 14 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR